In this study, we evaluated the antitumor efficacy of FMT from healthy human in combination with anti-PD-1 immunotherapy using CRC tumor-bearing mouse models and investigated the underlying mechanisms through multi-omics approaches. Here, PDCD1 is linked to colorectal carcinoma.